Six6 Inhibitors
Six6 inhibitors are a class of chemical compounds designed to specifically target and block the function of the Six6 protein, a member of the Six family of homeobox transcription factors. Six6 plays a crucial role in regulating the development and differentiation of various tissues, particularly in the eye and brain, where it is involved in processes such as retinal development and neurogenesis. Like other homeobox proteins, Six6 functions by binding to specific DNA sequences in the promoter regions of target genes, thereby controlling their expression. Inhibitors of Six6 are designed to disrupt this DNA-binding activity or interfere with its interaction with co-factors that assist in gene regulation. By inhibiting the function of Six6, these compounds prevent it from modulating the expression of genes that are critical for developmental pathways and cellular differentiation.
The development of Six6 inhibitors involves detailed structural and functional studies of the protein, particularly its DNA-binding domain and the regions that interact with other regulatory molecules. Researchers utilize techniques such as molecular modeling, X-ray crystallography, and computational docking to identify the key structural features of Six6 that are essential for its function. Inhibitors are then designed to bind to these specific sites, blocking the protein's ability to interact with DNA or its co-factors. Once synthesized, these inhibitors are evaluated using biochemical assays to assess their binding affinity, specificity, and their ability to inhibit the transcriptional activity of Six6. By studying Six6 inhibitors, researchers can explore the broader role of this transcription factor in gene regulation, tissue development, and cellular differentiation. This research helps to deepen the understanding of how transcription factors like Six6 influence developmental pathways and maintain cellular function.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine may decrease the expression of Six6 by inhibiting DNA methyltransferases, leading to the demethylation of its promoter region and subsequent transcriptional repression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A could downregulate Six6 expression through the inhibition of histone deacetylases, resulting in a more condensed chromatin structure around the Six6 gene, thus repressing its transcription. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
By inhibiting histone deacetylases, valproic acid may reduce Six6 expression via increased histone acetylation, which can lead to the suppression of transcription of the Six6 gene within the altered chromatin landscape. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) may specifically reduce Six6 expression by inhibiting histone deacetylases, which could result in chromatin remodeling that represses transcriptional activity at the Six6 locus. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid could downregulate Six6 by activating its receptors that bind to retinoic acid response elements in the genome, potentially leading to the repression of Six6 transcription as part of a coordinated response to retinoid signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
By inhibiting mTOR signaling, rapamycin may reduce Six6 expression as a secondary effect of dampened cellular growth signaling, which could indirectly lead to transcriptional repression of growth-related genes like Six6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY 294002 could lead to the downregulation of Six6 expression by blocking PI3K, which may disrupt downstream signaling pathways essential for maintaining Six6 transcriptional activity. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
Inhibiting the Hedgehog signaling pathway with cyclopamine may result in the downregulation of Six6 if Six6 expression is contingent upon pathway activation, leading to a decrease in transcriptional activity of the Six6 gene. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram may decrease Six6 expression by inhibiting aldehyde dehydrogenase and subsequently lowering retinoic acid synthesis, which is essential for the transcriptional regulation of some developmental genes, including potentially Six6. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059, as an inhibitor of MEK, could lead to a decrease in Six6 expression by preventing the activation of the MAPK/ERK pathway, which may be necessary for maintaining the transcriptional activity of the Six6 gene. | ||||||